REVANCE THERAPEUTICS
Live / Registered — Registered (as of 27 May 2025)
What this means for you
Registered since 27 May 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90862492
- Registration number
- 7811732
- Mark type
- Stylized text
- Filed
- 03 Aug 2021
- Published for opposition
- 21 Dec 2021
- Registered
- 27 May 2025
- Attorney of record
- Jennifer Waitman
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, muscle spasms, and pain; pharmaceutical preparations, namely, peptide substrates for use in the treatment of neurological disorders, muscle dystonias, muscle spasms, and pain
Owner
- Revance Therapeutics, Inc., GLENGORMLEY, DE, US
- Revance Therapeutics, Inc., Nashville, TN, US
- Revance Therapeutics, Inc., Nashville, TN, US
Prior registrations
Prosecution history
- 20 Jan 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 20 Jan 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 20 Jan 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 04 Aug 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 04 Aug 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 04 Aug 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 04 Aug 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 04 Aug 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 27 May 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 27 May 2025 — REGISTERED-PRINCIPAL REGISTER
- 05 May 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 05 May 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 30 Apr 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 14 Feb 2025 — USE AMENDMENT FILED
- 30 Apr 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL